At a glance
ClinicalIndex Comparison RecordN/AUnknown· 300 target
Drug / intervention
Vaccination +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study on Compliance, Safety and Effectivity of Vaccination for Children With Hematologic Malignancies or Solid Tumors and Their Parents
In Brief
A clinical study evaluating Vaccination and No Vaccination for Vaccination and 2 related conditions. Targeting 300 participants across 1 site.
Detailed Summary
The purpose of this study is to study on compliance, safety and effectivity of vaccination for children with hematologic malignancies or solid tumors and their parents.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVaccination, Hematologic Malignancy, Solid Tumor, Childhood
CountriesChina
Timeline
N/AUnknownOverdue
201820192020202120222023202420252026
Enrollment StartMay 2017
First PostedDec 2017
Primary CompletionJul 2025
Study CompletionSep 2025
TodayJul 2026
First PostedDec 14, 2017
Enrollment StartMay 1, 2017
Primary CompletionJul 1, 2025
Study CompletionSep 1, 2025
TodayJul 1, 2026
Enrollment to primary: 8.2 yearsPosted 8.5 years ago
Interventions
Vaccinationbiological
Patients with higher antibody titers will accept vaccination. There are two vaccines provided in this study: hepatitis B vaccine measles-rubella combined vaccine
No Vaccinationother
Patients with higher antibody titers will NOT accept vaccination. But we will keep monitoring their antibody titers.